FDA issued a Warning Letter to Forest Laboratories, Inc. on 8/7/2003 as a result of this inspection.
483 Allergan Sales Feb 2003

483 Allergan Sales Feb 2003

Frederick Lochner FDA, Mark Parmon FDA$119.00 - Available Now

FDA investigators audited the Allergan Sales - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 20 Feb 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Feb 2003
  • Location: Cincinnati, United States
  • FEI: 1523957
Add To Cart